Samples from a wastewater treatment plant were used as inocula for mixed cultures dosed with N-phenylpiperazine (NPP), a model compound containing the piperazine ring found in many fluoroquinolones. Chemical analyses showed that NPP (50 mg liter ؊1 ) disappeared in 12 days, with the appearance of a transient metabolite and two nitrosated compounds.
Municipal wastewater treatment plants (WWTPs) represent reservoirs for antimicrobial-resistant organisms and resistance genes that may spread by lateral gene transfer (4, 24) . Fluoroquinolone antimicrobials have been detected in WWTPs (6, 11, 14, 17, 22) , where most are expected to bind to sludge (6) , but some may be released via the final effluent (6, 11, 22) into the aquatic environment (8, 13, 26) . One strategy to limit proliferation of fluoroquinolone-resistant bacteria is to enhance biodegradation. Although fluoroquinolones are transformed by some fungi (10, 15, 19, 21, 27, 28) , information on bacterial transformation is limited (5) . Some bacteria modify ciprofloxacin and norfloxacin by N-acetylation or N-nitrosation, with no carbon loss (2, 3, 12, 16, 18, 23) but reduction of antibacterial activity (2) . The initial site of transformation of these fluoroquinolones is nearly always the piperazine moiety. Our intention was to test the ability of WWTP microorganisms to metabolize the piperazine ring in a model compound for fluoroquinolones.
Grab samples of aerobic reactor liquor and final effluent were taken from the Little Rock Wastewater Utility Treatment Plant (Little Rock, AR) in August 2006. Solid-phase extraction was performed on subsamples (2, 9), using 3-ml Waters SepPak C 18 cartridges with glass wool as a prefilter. The eluate was dried in vacuo, resuspended in 1 ml methanol, and analyzed by liquid chromatography-electrospray ionization-tandem mass spectrometry (LC/ESI-MS/MS) (2) with parent masses alternated between protonated molecules of fluoroquinolones and Q3 scanned from m/z 200 to 400 in 0.2 s (9). Ciprofloxacin was detected in the liquor at 750 ng liter Ϫ1 . Either ofloxacin or levofloxacin (not distinguishable under our conditions) was detected in the liquor at 500 ng liter Ϫ1 and in the effluent at 24 ng liter Ϫ1 ; the levels were consistent with other studies (6, 7, 11, 14) .
Assuming that a site containing fluoroquinolones may also (1) , by the mixed cultures was analyzed in lieu of fluoroquinolones, since it contains the piperazine ring found in many fluoroquinolones that is most often the site of initial enzymatic attack. Triplicate 50-ml volumes were inoculated with a final concentration of 0.5% (vol/vol) liquor. Cultures and triplicate sterile controls were dosed with filter-sterilized NPP (100 mg liter Ϫ1 ; Sigma); triplicate control cultures did not receive NPP. All flasks were incubated at 30°C with shaking at 200 rpm. Two ml was removed from each flask at each sampling time and adjusted above pH 8.5 with KOH. Samples were extracted three times with 2 ml ethyl acetate. The extracts were combined, dried in vacuo, and reconstituted with 400 l methanol for analysis.
Twenty l of prepared sample was injected into an Agilent Technologies 1100 high-performance liquid chromatography (HPLC) apparatus using an Inertsil 5-m ODS-3 column (250 by 4.6 mm; Phenomenex). The mobile phase consisted of a gradient of H 2 O-methanol (each with 10 mM NaOH) that increased from 25 to 75% methanol over 15 min, then from 75 to 100% over the next 5 min, and then was held at 100% for 5 min. The flow rate was 1 ml min Ϫ1 for the first 20 min and then 1.5 ml min Ϫ1 for 5 min. The diode array signal was set at 254 nm with a reference of 360 nm. External standard curves were generated for each substrate.
For LC/ESI-MS, full scans were acquired from m/z 90 to 550 in 1 s. For MS/MS identification of metabolites, the electrospray capillary temperature was 300°C and other conditions were the same as above. The mobile phase was a linear gradient at 0.2 ml min Ϫ1 of either 5 to 95% acetonitrile in water over 40 min with constant 21.7 mM formic acid (pH 3) or 5 to 90% of the same with constant 10 mM ammonium acetate (pH 7). Comparisons of retention times, UV spectra, and mass and product-ion spectra with those of standards resulted in identification, which was confirmed by 1 H nuclear magnetic resonance (NMR) spectroscopy (1, 20) .
When NPP (100 mg liter Ϫ1 ) was introduced as the sole carbon source, HPLC showed a reduction in the NPP peak and the appearance of new peaks at about 21 days. This trend continued through 42 days in the mixed cultures (Fig. 1A) , but NPP remained essentially unchanged in sterile controls (Fig.  1B) . The loss of NPP in 42 days did not exceed 50%. Mass spectrometric analysis of successfully degrading cultures at 21 days revealed a transient metabolite, peak I (Table 1) , which was identified by NMR (Table 2) , and an authentic standard (Aldrich) as N-phenylethylenediamine (PED) (Fig. 2) . Peak I had largely disappeared by 42 days (Fig. 1A) .
Two major transformation products (peaks II and IV in Fig.  1 ) were identified as N-nitroso-PED and N-nitroso-NPP, respectively (Tables 1 and 2 ; Fig. 2 ). Although the analyte of peak IV was relatively stable, that of peak II was unstable and required further confirmation. N-Nitroso-PED was synthesized by dissolving 10 mg PED and an equimolar amount of NaNO 2 in 2 ml H 2 O and purging with argon for 2 min. HCl was added until a pH of 5 was reached, and then the solution was stirred for 2 h (25).
Authentic PED was then introduced at 100 mg liter Ϫ1 into mixed cultures as a sole carbon source. Analysis by HPLC at 14 days showed no change in the PED substrate, but at 34 days it had completely disappeared, with the appearance of a single metabolite corresponding to peak II (Fig. 1A) . Direct exposure probe MS suggested a molecular weight of 165; the electrospray mass spectrum had ions at m/z 147, 136, and 106. The expected protonated molecule (m/z 166) was not observed, most likely due to instability. Product-ion spectra of the ions at m/z 147 and 136 were identical, with a major ion at m/z 106 and minor ions at m/z 79 and 77. Data for peak II (Table 1) were compared to those for synthetic N-nitroso-PED. They showed identical retention times, ESI mass spectra, product-ion mass spectra, and UV spectra at both pH 3 and pH 7. The chemical shifts of the NMR results for peak II (Table 2) were the same as those for the synthetic compound, further supporting the identification of N-nitroso-PED. a Compounds were dissolved in deuterated methanol; positions are numbered as for Fig. 2 (NPP) .
N-Acetyl-NPP and N-formyl-NPP (both eluting in peak III) (Fig. 1) were detected in cultures and sterile controls at levels of usually less than 1% of the starting substrate; the source is unknown.
In a separate experiment, molasses (Grandma's unsulfured) was added as a supplementary carbon source at 0.4% (vol/vol). WWTP liquor was inoculated for a final A 600 of 0.02. Cultures were dosed with either NPP (50 or 100 mg liter Ϫ1 ) or PED (100 mg liter Ϫ1 ). To avoid losing organic-insoluble metabolites, 0.1-ml samples were taken at intervals, filtered, and analyzed directly. Initial transformation of both compounds was more rapid with molasses. NPP at 100 mg liter Ϫ1 decreased in 12 days to 50% of the initial amount and then remained constant, but PED had completely disappeared by 7 days (Fig. 3) . When NPP was added at 50 mg liter Ϫ1 , all of it disappeared (Fig. 3) and the same metabolites (Table 1) were observed.
Overall, when NPP was used as a model substrate, PED was a transient intermediate and N-nitroso-NPP and N-nitroso-PED were the final products. Various human-associated bacteria mediate the nitrosation of drugs (2, 3, 29) ; N-nitrosonorfloxacin has less antibacterial activity than norfloxacin (2) . Some bacteria that remove an ethylene group from NPP may also be able to metabolize the piperazine ring of fluoroquinolones. Nevertheless, our experiments, which simplified the complexity of the WWTP environment, required an excessively long time for NPP modification. Future endeavors should include searches for bacteria that degrade specific fluoroquinolones and determination of optimal conditions for reducing environmental retention times for those fluoroquinolones. 
